Additionally, we adjusted NGAL, cystatin C, and NIRS (20′ after CPB) for all these parameters, confirming the significant independence of biomarkers and NIRS in predicting the incidence of CS-AKI (Table S2). This evidence concerns the gene LCN2 and acute kidney injury.